Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21221513rdf:typepubmed:Citationlld:pubmed
pubmed-article:21221513lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C1622501lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C1518174lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C0079419lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C0040649lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C0556643lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C0332183lld:lifeskim
pubmed-article:21221513lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:21221513pubmed:issue5lld:pubmed
pubmed-article:21221513pubmed:dateCreated2011-4-19lld:pubmed
pubmed-article:21221513pubmed:abstractTextThe p53 tumor suppressor exerts its function mainly as a transcriptional activator. Here we show that the Ras-related small GTPase Rad, an inhibitor of Rho kinase, is a direct transcriptional target of p53. Expression of Rad messenger RNA (mRNA) and protein was induced by DNA damage in a p53-dependent manner. The -2934/-2905-bp Rad promoter region, to which p53 bound, was required for p53-mediated Rad gene activation. Treatment by DNA damaging agents increased p53 occupancy and histone acetylation in the region of Rad promoter containing the p53-binding site. Expression of Rad diminished the inhibitory phosphorylation at Ser3 of cofilin, a regulator of actin dynamics, and suppressed migration and invasiveness of cancer cells. Knockdown of Rad promoted cell migration and alleviated the p53-mediated migration suppression. Frequent loss of Rad mRNA and protein expression was observed in non-small cell lung carcinoma tissues. Together our results reveal a mechanism that p53 may inhibit cell migration by disrupting actin dynamics via Rad activation and implicate a tumor suppressor role of Rad in lung cancer.lld:pubmed
pubmed-article:21221513pubmed:languageenglld:pubmed
pubmed-article:21221513pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21221513pubmed:citationSubsetIMlld:pubmed
pubmed-article:21221513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21221513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21221513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21221513pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21221513pubmed:statusMEDLINElld:pubmed
pubmed-article:21221513pubmed:monthMaylld:pubmed
pubmed-article:21221513pubmed:issn1432-1440lld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:HsuHan-ShuiHSlld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:WuYu-ChungYClld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:WangFung-Fang...lld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:ChouTeh-YingT...lld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:HsiehPei-Chen...lld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:ChenChun-Chin...lld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:ChangTsun-Kai...lld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:YehYi-ChenYClld:pubmed
pubmed-article:21221513pubmed:authorpubmed-author:HsiaoBo-YuanB...lld:pubmed
pubmed-article:21221513pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21221513pubmed:volume89lld:pubmed
pubmed-article:21221513pubmed:ownerNLMlld:pubmed
pubmed-article:21221513pubmed:authorsCompleteYlld:pubmed
pubmed-article:21221513pubmed:pagination481-92lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:meshHeadingpubmed-meshheading:21221513...lld:pubmed
pubmed-article:21221513pubmed:year2011lld:pubmed
pubmed-article:21221513pubmed:articleTitleRad is a p53 direct transcriptional target that inhibits cell migration and is frequently silenced in lung carcinoma cells.lld:pubmed
pubmed-article:21221513pubmed:affiliationInstitute of Biochemistry and Molecular Biology, National Yang-Ming University, 155 Li-Nong St., Taipei 112, Taiwan.lld:pubmed
pubmed-article:21221513pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21221513pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed